| 1 |
33258801 | Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis. | 2021 Feb |
2 |
| 2 |
33781961 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice. | 2021 Oct |
2 |
| 3 |
32130206 | Ψ-Xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance. | 2020 May |
1 |
| 4 |
32246809 | DPP-4 inhibitor reduces striatal microglial deramification after sensorimotor cortex injury induced by external force impact. | 2020 May |
2 |
| 5 |
32398684 | Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. | 2020 Nov |
1 |
| 6 |
30520247 | Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets. | 2019 Jul |
1 |
| 7 |
30597232 | Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings. | 2019 Mar 23 |
3 |
| 8 |
28368384 | GLP-1 acts on habenular avoidance circuits to control nicotine intake. | 2017 May |
2 |
| 9 |
28442582 | LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice. | 2017 Jul |
2 |
| 10 |
29184702 | Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion. | 2017 Nov 15 |
1 |
| 11 |
25580570 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. | 2015 Apr |
1 |
| 12 |
25694236 | Sitagliptin protects proliferation of neural progenitor cells in diabetic mice. | 2015 Aug |
4 |
| 13 |
25876091 | Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice. | 2015 |
1 |
| 14 |
25938560 | Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor. | 2015 |
4 |
| 15 |
26105952 | Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents. | 2015 Sep |
1 |
| 16 |
26665237 | Sitagliptin reduces urinary microalbumin in experimental model of diabetic nephropathy. | 2015 Sep-Dec |
1 |
| 17 |
24684301 | Activation of cAMP signaling attenuates impaired hepatic glucose disposal in aged male p21-activated protein kinase-1 knockout mice. | 2014 Jun |
1 |
| 18 |
24349326 | Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway. | 2013 |
1 |
| 19 |
22788747 | Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells. | 2012 Dec |
2 |
| 20 |
21673955 | Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. | 2011 |
1 |
| 21 |
18202141 | A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. | 2008 May |
1 |
| 22 |
18299314 | Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. | 2008 May |
1 |